United Drug could spend €50m a year widening international footprint
The Dublin-headquartered business, which last month delisted its shares from the Iseq in favour of the London exchange, is aiming to double its earnings by 2018 and increase its internationalisation. Already, 70% of group profits are generated outside of Ireland and by 2015 that figure is likely to have risen to 80%.
Yesterday, United issued a strong results covering the 12 months to the end of September. These showed group revenue up 5% to €1.83bn, a 10% rise in operating profits to €67.6m, and an 11% rise in pre-tax profits to €59m. Diluted earnings per share were up 11% to 19.89c and dividend per share rose 4% to 9.04c.
